Chugai Pharmaceutical : Personnel Changes

Personnel Changes

TOKYO, May 29, 2024 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following personnel changes, effective July 1, 2024.

[Details of Personnel Changes]

Executive Officers

	Name		New Responsibilities		Current Responsibilities
				Vice President			Vice President
						Head of Quality & Regulatory
				Head of Quality & Regulatory
						Compliance Unit and Head of
	Masayoshi Higuchi			Compliance Unit			Business Strategy & Compliance
				In charge of Risk & Compliance			Dept.
				Dept.			In charge of Risk & Compliance
							Dept.
Department Head
	Name			New Responsibilities			Current Responsibilities
				Head of Business Strategy &			Head of DX Strategy Planning
						Group, Business Strategy &
				Compliance Dept., Quality &
						Compliance Dept., Quality &
				Regulatory Compliance Unit,
	Mamoru Yoshida					Regulatory Compliance Unit,
			FNBP of Quality & Regulatory
						FNBP of Quality & Regulatory
				Compliance Unit and Finance &
						Compliance Unit and Finance &
				Accounting Dept.
						Accounting Dept.
Group Companies
	Name			New Responsibilities			Current Responsibilities
				Vice President		Head of Manufacturing Science and
				Head of Manufacturing Science
	Seiji Ueno				Technology Dept., Chugai Pharma
			and Technology Dept., Chugai
					Manufacturing Co., Ltd.
				Pharma Manufacturing Co., Ltd.
				Vice President		Head of Digital & Engineering Dept.,
				Head of Digital & Engineering
	Akira Kurabayashi				Chugai Pharma Manufacturing Co.,
			Dept., Chugai Pharma
					Ltd.
				Manufacturing Co., Ltd.

Introduction of executive officer system at Chugai Pharma Manufacturing Co., Ltd.

Chugai Pharmaceutical Manufacturing Co., Ltd.(Head office: Tokyo, President: Kenji Kamada), a member of the Chugai Group, will introduce executive officer system as of July 1, 2024, with the aim of speeding up management decision making and improving the efficiency of business execution.

###

2 / 2